Navigation Links
Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
Date:10/2/2007

Dana-Farber Campaign is Largest Hospital Fundraising Effort in New England

History

WATERTOWN, Mass., Oct. 2 /PRNewswire/ -- Corey McPherson Nash (CMN), the branding and design studio, is proud to recognize the successful design and development of the case statement supporting Dana-Farber Cancer Institute's capital campaign. CMN developed the case statement, along with additional branding and design work, to support Dana-Farber's efforts to secure the financial resources necessary to accelerate the pace of discovery, speed the application of scientific knowledge, and expand the Institute's ability to provide its signature total patient care.

"Our $1 billion goal marks the most ambitious capital campaign in the Institute's history," said Susan Paresky, Senior Vice President for Development at Dana-Farber Cancer Institute. "We have already seen a tremendous positive response to the campaign."

Dana-Farber Cancer Institute officially launched the campaign, "Mission Possible: The Dana-Farber Campaign to Conquer Cancer," in January 2007. "The success of the capital campaign for Dana-Farber Cancer Institute is extremely important to the Institute and to Corey McPherson Nash," said Michael McPherson, creative director and partner, CMN. "We worked closely with Dana- Farber to ensure that the visual components of this campaign reflect and reinforce the Institute's mission of saving lives. The results of this campaign will ensure that Dana-Farber continues the rigorous research and treatment to make this possible."

For more than 20 years, CMN has helped clients to enhance their communications with thoughtful branding and design. Visit the CMN website at http://www.cmndesign.com.

About Corey McPherson Nash

Corey McPherson Nash, a national branding and design studio, helps organizations achieve measurable brand equity across a wide variety of print and interactive communications. Their longstanding commitment to cause related issues has made it the branding firm of choice for a wide range of leading cultural and educational institutions. Widely recognized for its thoughtful design and strategic insights into the critical task of strategic brand iteration and creative development, CMN clients include OXFAM, The Huntington Theater Company, The Pan Mass Challenge, The Dana Farber Cancer Institute, the Museum of Science, Boston, and Children's Hospital Boston. Visit CMN online at http://www.cmndesign.com.


'/>"/>
SOURCE Corey McPherson Nash
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bioengineering production strains - Microbia develops new methods
2. Vical Biotech and NIH jointly develops HIV vaccine
3. Kirin Develops a Cure for Bird Flu
4. Starpharma Develops New Gel (Vivagel) To Prevent HIV Transmission
5. Georgia Institute of Technology develops doppler Vein finder
6. Hungary Develops New Bird Flu Vaccine
7. Dutch chemical group Akzo Nobel Develops A New Bird Flu Vaccine
8. ICAR develops bird flu vaccine
9. Samsung Develops Device to Measure Body Fat
10. India Develops Test for Diagnosis of Deadly Livestock Disease
11. Mouth Cancer Develops In Two Different Ways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: